Do different atrial flutter types carry the same thromboembolic risk?

Angiology

Volumn 56, Issue 5, 2005, Pages 593-599

  Demir, Ahmet Duran ^a,b   Soylu, Mustafa ^a,b   Özdemir, Özcan ^a,b   Topaloǧlu, Serkan ^a,b   Aras, Dursun ^a,b   Şaşmaz, Ali ^a,b   Korkmaz, Şule ^a,b  

^a Türkiye Yüksek Ihtisas Hospital ^*

^b Harbiye Mah   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART RATE; HUMAN; MALE; RISK; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGE FACTORS; AGED; ANTICOAGULANTS; ATRIAL FLUTTER; BLOOD COAGULATION DISORDERS; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; THROMBOEMBOLISM;

EID: 25644437752     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970505600511     Document Type: Article

References (25)

1. Arnold AZ, Mick MJ, Mazurek RP, et al: Role for prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 19:851-855, 1992.
2. Grimm RA, Sewart WJ, Arheart KL, et al: Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 29:582-589, 1997.
3. Omran H, Jung W, Rabahieh R, et al: Left atrial appendage function in patients with atrial flutter. Heart 78:250-254, 1997.
4. Kinch JW, Davidoff R: Prevention of embolie events after cardioversion of atrial fibrillation: Current and evolving strategies. Arch Intern Med 155:1353-1360, 1995.
5. Seidl K, Hauer B, Schwick NG, et al: Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 82:580-583, 1998.
6. Schimidt H, Recke GVD, İllien S, et al: Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol 38:778-784, 2001.
7. Corrado G, Sgalambro A, Mantero A, et al, for the FLASIEC investigators: Thromboembolic risk in atrial flutter. Eur Heart J 22:1042-1051, 2001.
8. Irani WN, Grayburn PA, Afridi I: Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. Circulation 95:962-966, 1997.
9. Santiago D, Warshofsky M, Mandri G, et al: Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study. J Am Coll Cardiol 24:159-164, 1994.
10. Gilligan DM, Burch M, Fuller IA, et al: High prevalence of left atrial thrombi in patients with typical atrial flutter and left ventricular systolic dysfunction (abstract). J Am Coll Cardiol 33:117A, 1998.
11. Weiss R, Marcovitz P, Knight BP, et al: Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter. Am J Cardiol 82:1052-1055, 1998.
12. Laupacis A, Boyser G, Connoly S, et al: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449-1457, 1994.
13. Fatkin D, Herbert E, Feneley MP: Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 73:672-676, 1994.
14. Leung DYC, Black IW, Cranney GB, et al: Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 24:755-762, 1994.
15. Jones EF, Calafiore P, McNeil JJ, et al: Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke. Am J Cardiol 78:425-429, 1996.
16. Wood KA, Eisenberg SJ, Kaiman JM, et al: Risk of thromboembolism in chronic atrial flutter. Am J Cardiol 79:1043-1047, 1997.
17. Lanzarotti CL, Olshansky B: Thromboembolism in chronic atrial flutter: Is the risk underestimated? J Am Coll Cardiol 30:1506-1511, 1997.
18. Lip GYH, Lowe GDO, Rumley A, et al: Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J 131:724-730, 1996.
19. Sohora H, Amitani S, Kurose M, et al: Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 29:106-112, 1997.
20. Fatkin D, Kelly RP, Feneley MP: Relations between left atrial appendage blood flow velocity, spontaneous echo contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23:307-316, 1994.
21. Tsai LM, Chen JH, Fang CJ, et al: Clinical implications of left atrial spontaneous echo contrast in non-rheumatic atrial fibrillation. Am J Cardiol 70:327-331, 1992.
22. Feinberg WM, Pearce LA, Hart RG, et al: Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1,531 participants in the Stroke Prevention in Atrial Fibrillation III study. Stroke 30:2547-2553, 1999.
23. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 118:956-963, 1993.
24. Lip GYH, Lowe GDO: Fibrin D-dimer: A useful clinical marker of thrombogenesis? Clin Sci 89:205-214, 1995.
25. Asakura H, Hifumi S, Jokaji H, et al: Prothrombin fragment F1+2 and thrombin-antithrombin III complex are useful remarkers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis 3:469-473, 1992.